Summary & Overview
Inguinal and Femoral Hernia Procedures without CC/MCC: Inpatient Reimbursement Overview
DRG 352 covers inpatient stays for inguinal and femoral hernia repair when no Complication or Comorbidity or Major Complication or Comorbidity is present, representing low-acuity surgical admissions. This grouping matters for inpatient reimbursement because it establishes the bundled Medicare payment and affects hospital billing, length-of-stay expectations, and resource planning.
DRG 352 Overview
DRG 352 encompasses inpatient admissions for elective or noncomlicated surgical repair of inguinal and femoral hernias without a Complication or Comorbidity and without a Major Complication or Comorbidity. This Diagnosis-Related Group covers typical cases where patients undergo hernia repair with an expected uncomplicated recovery and short length of stay. It matters for Medicare payment because it groups similar low-acuity surgical admissions into a single bundled payment rate that influences hospital revenue and resource allocation. Accurate coding and principal procedure documentation determine assignment to this Diagnosis-Related Group.
Clinical Trials
- Perioperative analgesia and opioid-sparing strategies for elective open and laparoscopic inguinal or femoral hernia repair: randomized or pragmatic trials comparing regional anesthesia techniques (e.g., ilioinguinal/iliohypogastric nerve blocks), multimodal non-opioid analgesic regimens, or enhanced recovery protocols in adults undergoing uncomplicated hernia repair. The patient population includes adults without major comorbidities (consistent with DRG 352) presenting for primary elective repair; outcomes measured include postoperative pain scores, opioid consumption, length of stay, and return to normal activity. This research is relevant to providers and payers because effective pain control that reduces opioid use and shortens hospital stay can improve patient throughput, reduce complication-related costs, and align with value-based payment incentives.
- Comparative effectiveness studies of surgical approach and perioperative resource use: observational cohorts or randomized trials comparing open tissue-based repair versus mesh-based open repair versus laparoscopic (totally extraperitoneal or transabdominal preperitoneal) techniques in straightforward inguinal and femoral hernias. These studies focus on operative time, intraoperative and immediate postoperative complications, hospital admission rates, readmissions within 30 days, and need for conversion or reoperation in generally healthy patients captured under this DRG. Findings inform clinicians and payers about which techniques provide the best balance of clinical outcomes, operative costs, and short-term resource utilization for low-acuity hernia admissions.
- Post-discharge functional recovery, return-to-work, and health economics studies: prospective cohort studies or pragmatic trials assessing recovery trajectories, patient-reported outcomes (pain, quality of life, activity levels), and short-term healthcare utilization (urgent visits, physical therapy, analgesic prescriptions) after discharge following uncomplicated hernia repair. The population includes working-age adults and older patients without CC/MCC who are expected to have short inpatient stays; analyses evaluate predictors of delayed recovery and the cost implications of postoperative complications or unplanned services. This area is important for discharge planning and payer policy because improved understanding of recovery can guide case management, reduce unnecessary post-discharge spending, and support bundled-payment or episode-based reimbursement strategies.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.